Kanghua Biological released its performance for the first three quarters, with a net profit attributable to the parent company of 189 million yuan, a decrease of 53.41%
According to the Zhitong Finance APP, Kanghua Biological released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 840 million yuan, a year-on-year decrease of 20.78%. The net profit attributable to shareholders of the listed company was 189 million yuan, a year-on-year decrease of 53.41%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 183 million yuan, a year-on-year decrease of 55.57%. The basic earnings per share were 1.4553 yuan
According to the Zhitong Finance APP, Kanghua Biological (300841.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 840 million yuan, a year-on-year decrease of 20.78%. The net profit attributable to shareholders of the listed company was 189 million yuan, a year-on-year decrease of 53.41%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 183 million yuan, a year-on-year decrease of 55.57%. The basic earnings per share were 1.4553 yuan
